Indefinite Delivery Contract SPE2D222D0146
Award Date
8/31/22
Last Date to Order
8/30/27
Federal Agency
Medical Supply Chain
Awardee
Teva Pharmaceuticals Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The key details of this federal contract IDV award are as follows: The National Acquisition Center of the Department of Veterans Affairs (VA) awarded a $109,085,460 single-award Indefinite Delivery Contract (IDC) to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide an uninterrupted supply of Albuterol HFA inhalers with dose counters. This contract has an initial one-year period of performance with four one-year option periods, for a total...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Teva Pharmaceuticals USA, Inc., a foreign-owned pharmaceutical manufacturer, for the supply of glatiramer acetate injections. The $64,352,514.80 contract has a base period of one year and four one-year option periods, running from August 2023 to August 2025. This IDC will ensure the delivery of approximately 208,000 syringes of glatiramer acetate 20mg/mL and 40mg/mL...
The federal contract indefinite delivery vehicle (IDV) award V797D70217 is a multiple-award Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, held by Teva Pharmaceuticals USA, Inc. The contract has a period of performance through August 31, 2025 and a $3.6 billion ceiling value. As a prime vendor to various federal agencies including the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons, and Indian Health Service,...
This federal contract IDV, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a single-award Indefinite Delivery Contract (IDC) with Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The primary focus of this contract is the delivery of Adenovirus Type 4 vaccines, which support military immunization programs. Through multiple firm-fixed-price delivery orders issued under this IDC, Teva Pharmaceuticals USA, Inc. will provide the DLA with...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The $29,031,544.57 IDC covers the delivery of a wide range of branded and generic pharmaceutical products to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service through August 2029. Key items include medications such as ibuprofen, citalopram, albuterol,...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceuticals. The contract, valued at up to $2,337,840, is for the delivery of Albuterol SO4 tablets to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS) over a one-year base period plus four one-year option periods. This IDC was...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency within the Department of Veterans Affairs (VA), to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The contract has a ceiling value of $40,480,225.15 and a period of performance from February 12, 2022 to February 11, 2023, with four one-year option periods. The contract was awarded to provide an uninterrupted supply of various strengths and package sizes of...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The single-award IDC, valued at up to $6,984,109.81, has an ultimate completion date of February 11, 2029. Under this contract, Exelan Pharmaceuticals will provide a variety of generic pharmaceutical products to the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through...
The federal contract IDV award, valued at $26,366,625,013.21, was issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This single-award Indefinite Delivery Contract (IDC) has an ultimate completion date of March 6, 2035 and supports the TRICARE North program. The purpose of this IDC is to establish Prime Vendor Contracts for the Pharmaceutical Prime Vendor Global...
This Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to Avkare LLC, a pharmaceutical and medical supply company, has a total ceiling value of $10,373,182.60. The contract is for the manufacture and distribution of various pharmaceutical and medical products, including generic medications such as cephalexin, prednisone, sulfamethoxazole-trimethoprim, and primaquine phosphate tablets, as well as medical equipment and supplies like urinalysis testing materials and...